Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.75 -0.02 (-0.23%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.75 -0.02 (-0.23%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth D Momentum D VGM
Zacks News
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $40.61, marking a -1.36% move from the previous day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $43.55 in the latest trading session, marking a +0.9% move from the prior day.
Company News for May 13, 2022
by Zacks Equity Research
Companies in The News Are: ABC, WBA, COIN, CEG, TPR
Here's Why You Should Hold on to Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA) owing to the recent product launches.
Walgreens (WBA) Expands Medical Care Offerings in California
by Zacks Equity Research
Walgreens' (WBA) new initiative is intended to reduce care gaps and advance care management by providing access to more affordable and convenient services.
Company News for Apr 1, 2022
by Zacks Equity Research
Companies In The News Are: WBA, XOM, JPM, VNET.
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Strong execution across business segments, led by COVID-19 vaccinations and testing, drove Walgreens' (WBA) fiscal second-quarter top line.
Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 14.39% and 0.19%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview.
Breaking Down the Outlook for S&P 500 Margins
by Sheraz Mian
Revisions to the 2022 Q1 estimates are mixed, with estimates for 9 of the 16 Zacks sectors going down since the start of January, with the Consumer Discretionary, Transportation and Aerospace sectors suffering significant estimate cuts...
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $47.43 in the latest trading session, marking a +0.11% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into New Hampshire
by Zacks Equity Research
Walgreens (WBA) and VillageMD are working together to make it easier for the communities to access high-quality, coordinated primary care and pharmacy services.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most. However, reimbursement challenges are hurting the industry's health.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.17, marking a +0.54% move from the previous day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.12 in the latest trading session, marking a +1.37% move from the prior day.
Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp
by Zacks Equity Research
Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $46.72, moving +1.24% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Moves -0.72%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $45.46, marking a -0.72% move from the previous day.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.30, marking a +1.98% move from the previous day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.99 in the latest trading session, marking a +0.4% move from the prior day.
Walgreens Boots Alliance (WBA) Stock Moves -1.81%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.50 in the latest trading session, marking a -1.81% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into Arizona
by Zacks Equity Research
Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening eight new Village Medical at Walgreens primary care practices in the Tucson area.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots' (WBA) robust growth in the International segment and strong first-quarter fiscal 2022 results.
Walgreens Boots (WBA) Q1 Earnings Top Estimates, 2022 View Up
by Zacks Equity Research
Walgreens Boots' (WBA) revenues increased year over year in the fiscal first quarter, driven by COVID-19 vaccinations and testing.
Walgreens Boots Alliance (WBA) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 24.44% and 2.71%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?